Brief: China NT Pharma Group Co Posts HY Profit Attributable RMB82.9 Mln
21/08/2018 16:00
Aug 21 (Reuters) - China NT Pharma Group Co Ltd 1011.HK :
* HY REVENUE FROM CONTINUING OPERATIONS RMB312 MILLION
VERSUS
RMB314.4 MILLION
* HY PROFIT ATTRIBUTABLE RMB82.9 MILLION VERSUS RMB80.7
MILLION
Source text for Eikon: ID:nHKS2Y2HSL
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY